![Carey Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carey Ng
Direktor/Vorstandsmitglied bei
IMMIX BIOPHARMA, INC.
Vermögen: 15 Mio $ am 31.08.2026
Profil
Carey J.
Ng is currently Managing Director at Mesa Verde Ventures LLC since 2013 and at Mesa Verde Venture Partners LP since 2013.
Dr. Ng serves as Director at Satiogen Pharmaceuticals, Inc., Elysium Therapeutics, Inc., Paradigm Diagnostics, Inc., and MatriSys Bioscience, Inc. Dr. Ng is Independent Director at Immix Biopharma, Inc. since 2019.
Formerly, Dr. Ng was Director at Biscayne Neurotherapeutics, Inc. Dr. Ng earned a doctorate from the University of California, Los Angeles in 2004 and an MBA from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.05.2026 | 1’045’221 ( 1.46% ) | 15 Mio $ | 31.08.2026 |
Aktive Positionen von Carey Ng
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMIX BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.11.2019 |
Satiogen Pharmaceuticals, Inc.
 Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Direktor/Vorstandsmitglied | - |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Private Equity Investor | 01.01.2008 |
Paradigm Diagnostics, Inc.
 Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic systems | Direktor/Vorstandsmitglied | - |
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | - |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Direktor/Vorstandsmitglied | - |
Mesa Verde Venture Partners LP
 Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01.12.2013 |
Ehemalige bekannte Positionen von Carey Ng
| Unternehmen | Position | Ende |
|---|---|---|
Biscayne Neurotherapeutics, Inc.
 Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Direktor/Vorstandsmitglied | - |
Ausbildung von Carey Ng
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic systems | Health Technology |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Mesa Verde Venture Partners LP
Mesa Verde Venture Partners LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Health Technology |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Immix Biopharma, Inc.
 Immix Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cancer patients | Health Technology |
